SCHEMBL7217145

SCHEMBL7217145

COC(=O)c1cccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 2/20 0.59
MAPT P10636 4/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
EIF4E P06730 4/20 0.49
SDHB P21912 1/20 0.49
NR1H4 Q96RI1 1/20 0.48
TP53 P04637 1/20 0.48
SIRT5 Q9NXA8 2/20 0.47
CDC25A P30304 1/20 0.47
CDC25B P30305 1/20 0.47
CDC25C P30307 1/20 0.47
DUSP3 P51452 1/20 0.47
MAPK1 P28482 2/20 0.46
HSD17B1 P14061 1/20 0.46
HSD17B2 P37059 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215544 0.92 ALDH1A1 (0.67) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL7221406 0.87 MAPT (0.59) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL7221341 0.86 KDM4E (0.74) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL7217144 0.85 KDM4E (0.62) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL7215074 0.84 CYP19A1 (0.50) KDM4EMEN1KMT2AALDH1A1NPC1
SCHEMBL7220984 0.84 RAB9A (0.55) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL27538601 0.82 SDHB (0.57) KDM4EMEN1KMT2AALDH1A1NPC1
SCHEMBL7215657 0.81 CDC25A (0.60) KDM4EKMT2AALDH1A1MAPTNPC1
SCHEMBL28507787 0.80 CA12 (0.59) SDHB
SCHEMBL29917375 0.80 CA12 (0.59) SDHB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545009-B1 Imidazole, oxazole and thiazole derivatives for regulation of peroxisome proliferator-activated receptor function; improving insulin resistance, treating impaired glucose tolerance and obesity, enhancing insulin sensitivity, etc. TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-08 US disclosed
EP-1092711-A1 RETINOID-ASSOCIATED RECEPTOR REGULATORS Takeda Chemical Industries, Ltd. (JP) 2001-04-18 EP disclosed